Pallas Health
Pallas Health is a telehealth technology platform operated by Brentmoor, Inc. Pallas doesn’t employ clinicians directly; care is delivered by Lion MD, a nationwide network of independently licensed U.S. physicians, coordinated through the CareValidate clinical-operations platform. Medical leadership is named and independently verifiable: Dr. Ana Lisa Carr, MD (board-certified in family, obesity, and addiction medicine) and Dr. Kelly Tenbrink, MD (board-certified in emergency medicine), both with NPI numbers published on Pallas’s own Clinical Disclosures page. Pallas reports serving over 200,000 patients and holds a 4.8-out-of-5 rating from more than 2,400 member reviews. Unlike most compounded-only competitors, Pallas offers a genuine choice: FDA-approved brand-name GLP-1 medications, or compounded semaglutide and tirzepatide, prescribed only when a clinician determines it’s clinically appropriate. Compounded prescriptions are filled by one of six named, U.S.-licensed compounding pharmacies depending on medication and state. Pallas is LegitScript certified and publishes an unusually detailed compliance page covering its provider network, dispensing pharmacies, and data-handling practices — more transparent than most brands we’ve reviewed in this category.